Volitionrx (VNRX) Profit After Tax (QoQ) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Volitionrx | 101.83 Mn | 99.36 Mn | -1.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -18.62% |
| Sep 30, 2025 | 14.32% |
| Jun 30, 2025 | -15.29% |
| Mar 31, 2025 | 6.50% |
| Dec 31, 2024 | -0.61% |
| Sep 30, 2024 | 17.54% |
| Jun 30, 2024 | 16.66% |
| Mar 31, 2024 | 3.72% |
| Dec 31, 2023 | -4.10% |
| Sep 30, 2023 | 11.50% |
| Jun 30, 2023 | -7.65% |
| Mar 31, 2023 | -20.95% |
| Dec 31, 2022 | 6.09% |
| Sep 30, 2022 | -1.04% |
| Jun 30, 2022 | -0.18% |
| Mar 31, 2022 | 4.81% |
| Dec 31, 2021 | -12.90% |
| Sep 30, 2021 | -29.94% |
| Jun 30, 2021 | 9.77% |
| Mar 31, 2021 | -19.24% |
| Dec 31, 2020 | -18.70% |
| Sep 30, 2020 | 14.08% |
| Jun 30, 2020 | 13.89% |
| Mar 31, 2020 | -64.44% |
| Dec 31, 2019 | 14.91% |
| Sep 30, 2019 | -0.57% |
| Jun 30, 2019 | 1.11% |
| Mar 31, 2019 | 1.95% |
| Dec 31, 2018 | 4.23% |
| Sep 30, 2018 | 2.51% |
| Jun 30, 2018 | 1.30% |
| Jun 30, 2013 | -15.39% |
| Mar 31, 2013 | 38.55% |
| Dec 31, 2012 | -69.32% |
| Sep 30, 2012 | 6.33% |
| Jun 30, 2012 | -16.18% |
| Mar 31, 2012 | 12.61% |
| Dec 31, 2011 | -28.20% |
| Sep 30, 2011 | -11.80% |
| Jun 30, 2011 | -90.99% |